Trump Administration Announces Drug Pricing Deals With Teva and Other Firms
International pharmaceutical companies agreed to cut some drug prices for federal health programs and to sell certain medicines directly to patients through a Trump-branded website. In return, they received tariff relief. The administration said the deals build on most-favored-nation pricing offered to Medicaid and could reduce costs, but it’s unclear how much savings will result for governments or patients.
Coverage (7)
- Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S. (wahanariau.com)
- Trump's Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing (beincrypto.com)
- Trump's New Drug Pricing Agreement: Nine Companies Involved (gurufocus.com)
- Trump announces new drug-pricing deals with 9 pharma companies (nbcnews.com)
- Trump announces deal with 9 new pharmaceutical firms in move to ease drug costs (cbsnews.com)
- Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report (pharmexec.com)
- Trump administration announces drug pricing deals with Teva, Astellas and others (reuters.com)